Burning Rock Announces US$10 Million Share Repurchase Program
June 21, 2022 02:03 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 19, 2021 05:06 ET
|
Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
Burning Rock to be Added to MSCI China Index
May 12, 2021 04:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, May 12, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
December 15, 2020 01:33 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
December 04, 2020 06:34 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
December 01, 2020 18:47 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Third Quarter 2020 Financial Results
November 20, 2020 06:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
November 15, 2020 20:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into a development and...
Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
October 29, 2020 23:21 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that analytical validation data of its fully-automated...
Burning Rock Announces Preliminary Third Quarter 2020 Results and Schedules Earnings Release on November 20, 2020
October 20, 2020 21:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...